RESULTS OF A PHASE 2 STUDY OF RG6125, AN ANTI-CADHERIN-11 MONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO ANTI-TNFALPHA THERAPY

被引：17
|
作者：
Finch, Rebecca [1 ]
Sostelly, Alexandre [2 ]
Sue-Ling, Kim [3 ]
Blaeuer, Angela [2 ]
Duchateau-Nguyen, Guillemette [2 ]
Ukarma, Lidia [2 ]
Petry, Claire [2 ]
Ravva, Patanjali [2 ]
Villiger, Peter [4 ]
Junker, Uwe [2 ]
机构：
[1] Roche Prod Ltd, Welwyn Garden City, England
[2] Roche Innovat Ctr Basel, Basel, Switzerland
[3] Roche Innovat Ctr New York, New York, NY USA
[4] Inselspital Bern, Bern, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0224
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [21] Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study
    Li, Z.
    Hu, J.
    Bao, C.
    Li, X.
    Li, X.
    Xu, J.
    Spindler, A. J.
    Zhang, X.
    Xu, J.
    He, D.
    Li, Z.
    Wang, G.
    Yang, Y.
    Wu, H.
    Ji, F.
    Tao, H.
    Zhan, L.
    Bai, F.
    Rooney, T. P.
    Zerbini, C. A. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : 732 - 741
  • [22] Inadequate Clinical Response to Sirukumab, an Anti-IL-6 Monoclonal Antibody, Can be Predicted after a Single Dose of Treatment in Patients with Rheumatoid Arthritis
    Daga, Shruti
    Aletaha, Daniel
    Hsu, Benjamin
    Gilbride, Jennifer
    Christie, Jacquie
    Loza, Matthew
    Dasgupta, Bidisha
    Campbell, Kim
    Brown, Kurt
    Rao, Ravi
    Tak, Paul P.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [23] The efficacy and safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Emery, P.
    Pritchard, C.
    Zhou, X.
    Genovese, M.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II45 - II45
  • [24] Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Nanki, Toshihiro
    Umehara, Hisanori
    Yasuda, Nobuyuki
    Tago, Fumitoshi
    Kitahara, Yasumi
    Kawakubo, Makoto
    Torii, Kentaro
    Hojo, Seiichiro
    Kawano, Tetsu
    Imai, Toshio
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (04) : 587 - 595
  • [25] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy -: Comment
    Emery, P
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 768 - 768
  • [26] Integrated Phase 3 Safety Results of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis
    Aletaha, Daniel
    Thorne, Carter
    Schiff, Michael
    Harigai, Masayoshi
    Agarwal, Prasheen
    Rao, Ravi
    Cohen, Christopher
    Cheng, Ben
    Brown, Kurt
    Hsu, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [27] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Hirabara, Shinya
    Takahashi, Nobunori
    Fukaya, Naoki
    Miyake, Hiroyuki
    Yabe, Yuichiro
    Kaneko, Atsushi
    Ito, Takayasu
    Oguchi, Takeshi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Sugiura, Fumiaki
    Hayashi, Masatoshi
    Funahashi, Koji
    Hanabayashi, Masahiro
    Asai, Shuji
    Ishiguro, Naoki
    Kojima, Toshihisa
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1247 - 1254
  • [28] Response to pneumococcal vaccine in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy treated with abatacept in the arrive trial
    Schiff, M.
    Kaell, A.
    Tay, L.
    Vratsanos, G.
    Bahrt, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 437 - 437
  • [29] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Shinya Hirabara
    Nobunori Takahashi
    Naoki Fukaya
    Hiroyuki Miyake
    Yuichiro Yabe
    Atsushi Kaneko
    Takayasu Ito
    Takeshi Oguchi
    Daihei Kida
    Yuji Hirano
    Takayoshi Fujibayashi
    Fumiaki Sugiura
    Masatoshi Hayashi
    Koji Funahashi
    Masahiro Hanabayashi
    Shuji Asai
    Naoki Ishiguro
    Toshihisa Kojima
    Clinical Rheumatology, 2014, 33 : 1247 - 1254
  • [30] Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study
    Schiff, Michael
    Combe, Bernard
    Doerner, Thomas
    Kremer, Joel M.
    Huizinga, Thomas W.
    Veenhuizen, Melissa
    Gill, Anne
    Komocsar, Wendy
    Berclaz, Pierre-Yves
    Ortmann, Robert
    Lee, Chin
    RMD OPEN, 2015, 1 (01):
12345